| Merck Announces FDA Acceptance of Supplemental New Drug ... - Business Wire (press release) |
|
|
... myocardial infarction, gastritis, hepatitis, herpes simplex, toxic nephropathy, renal failure, chronic renal failure and renal tubular necrosis. ... |